Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 12, 2025Open Access

Integrated Systems Oncology: A Multimodal Framework for Addressing Cancer Heterogeneity

View Full Paper
Ask AI
Bookmark
Share

Authors

DID.S. Islam

Discussion

Loading...

Member takes

Overview

This approach integrates therapies targeting genetic and immune heterogeneity in cancer, highlighting clinical implications.

Key Points

  • This framework addresses cancer heterogeneity, aiming to reduce therapeutic resistance by combining multiple treatment strategies.
  • The integrated systems oncology approach utilizes AI-driven therapies, including CRISPR technologies and targeted epigenetic interventions.
  • The proposal emphasizes personalized treatment plans tailored to individual patient profiles and specific cancer subtypes for improved outcomes.
  • It presents significant global health implications by advocating for accessible cancer therapies through equitable models and decentralized production.

Cite This Study

D.S. Islam (2025) studied this question.

synapsesocial.com/papers/68ebc91af2c3e4d8d926e2f4https://doi.org/10.20944/preprints202510.0570.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer: From a Genetic Disorder to a Systemic Disease2025
  2. 2Omics-driven networks herald a new era of multidimensional therapy for cholangiocarcinoma2025
  3. 3Reprogramming cancer immunity with next-generation combination therapies2025 · 25 citations
  4. 4Editorial: Formation of immunological niches in tumor microenvironments: mechanisms and therapeutic potential2025 · 2 citations
  5. 5Precision theranostics in oncology: integrating antibody-drug conjugates, radioimmunotherapy, and immuno‑PET for adaptive cancer care2026